As several companies are in the race to create antibody tests to get people back to work and end lockdowns, there is a greater need for the blood of those who have recovered from COVID-19. Other companies are stepping in to solicit blood donations from patients and then selling the blood to labs and test manufacturers at a premium. The more antibodies in the blood, the higher the price... some samples are selling anywhere from $350 to $40,000. Some of the companies involved said they are not profiteering and the steps in obtaining the blood is very complex. Jane Bradley, investigative reporter for the NY Times, joins us for the lucrative trade in human blood samples.




Next, Florida has begun to reopen the state for business as they were able to dodge some of the worst of the coronavirus. Despite not issuing early statewide stay-at-home orders, many of the decisions were left to local authorities to shut down. A lesser population density and warmer climate could also have played a role in fewer infections, but one other factor, there was an attitude change in Florida residents themselves. Smartphone data shows that by mid-March, before stay-at-home orders were put in place, residents had already begun to hunker down and limit movements. Still with a larger population of people over 65, fears of a second wave of infections persist. Arian Campo- Flores, reporter at the WSJ, joins us for how Florida made it this far.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.